188 related articles for article (PubMed ID: 16756586)
1. Effectiveness of community treatment orders for treatment of schizophrenia with oral or depot antipsychotic medication: clinical outcomes.
Muirhead D; Harvey C; Ingram G
Aust N Z J Psychiatry; 2006; 40(6-7):596-605. PubMed ID: 16756586
[TBL] [Abstract][Full Text] [Related]
2. Community treatment orders and antipsychotic long-acting injections.
Lambert TJ; Singh BS; Patel MX
Br J Psychiatry Suppl; 2009 Nov; 52():S57-62. PubMed ID: 19880919
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of community treatment orders for treatment of schizophrenia with oral or depot antipsychotic medication: changes in problem behaviours and social functioning.
Ingram G; Muirhead D; Harvey C
Aust N Z J Psychiatry; 2009 Nov; 43(11):1077-83. PubMed ID: 20001403
[TBL] [Abstract][Full Text] [Related]
4. Community treatment orders: relationship to clinical care, medication compliance, behavioural disturbance and readmission.
Vaughan K; McConaghy N; Wolf C; Myhr C; Black T
Aust N Z J Psychiatry; 2000 Oct; 34(5):801-8. PubMed ID: 11037366
[TBL] [Abstract][Full Text] [Related]
5. Naturalistic outcomes of community treatment orders: antipsychotic long-acting injections versus oral medication.
Patel MX; Matonhodze J; Baig MK; Taylor D; Szmukler G; David AS
J Psychopharmacol; 2013 Jul; 27(7):629-37. PubMed ID: 23676196
[TBL] [Abstract][Full Text] [Related]
6. Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study.
Brnabic AJ; Kelin K; Ascher-Svanum H; Montgomery W; Kadziola Z; Karagianis J
Int J Clin Pract; 2011 Sep; 65(9):945-53. PubMed ID: 21849009
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs.
Kirson NY; Weiden PJ; Yermakov S; Huang W; Samuelson T; Offord SJ; Greenberg PE; Wong BJ
J Clin Psychiatry; 2013 Jun; 74(6):568-75. PubMed ID: 23842008
[TBL] [Abstract][Full Text] [Related]
8. Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials.
Leucht C; Heres S; Kane JM; Kissling W; Davis JM; Leucht S
Schizophr Res; 2011 Apr; 127(1-3):83-92. PubMed ID: 21257294
[TBL] [Abstract][Full Text] [Related]
9. Assessing the outcome of compulsory treatment orders on management of psychiatric patients at 2 McGill University-associated hospitals.
Nakhost A; Perry JC; Frank D
Can J Psychiatry; 2012 Jun; 57(6):359-65. PubMed ID: 22682573
[TBL] [Abstract][Full Text] [Related]
10. Community treatment orders.
Ridley G
Br J Psychiatry; 1993 Sep; 163():417. PubMed ID: 8104655
[No Abstract] [Full Text] [Related]
11. A retrospective study of psychotropic drug use among individuals with mental illness issued a community treatment order.
Gisev N; Bell JS; Chen TF
Int J Clin Pract; 2014 Feb; 68(2):236-44. PubMed ID: 24372715
[TBL] [Abstract][Full Text] [Related]
12. A cluster analysis of people on Community Treatment Orders in Victoria, Australia.
Brophy LM; Reece JE; McDermott F
Int J Law Psychiatry; 2006; 29(6):469-81. PubMed ID: 17084453
[TBL] [Abstract][Full Text] [Related]
13. [The significance of depot medication in the long-term-treatment of schizophrenia].
Kühn KU; Wiedemann K; Hellweg R; Möller HJ
Fortschr Neurol Psychiatr; 2014 Oct; 82(10):557-65. PubMed ID: 25299626
[TBL] [Abstract][Full Text] [Related]
14. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
[TBL] [Abstract][Full Text] [Related]
15. The effect of financial incentives on patients' motivation for treatment: results of "Money for Medication," a randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
BMC Psychiatry; 2018 May; 18(1):144. PubMed ID: 29793451
[TBL] [Abstract][Full Text] [Related]
16. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
17. Comparison of treatment discontinuation and hospitalization among nonadherent patients initiating depot or oral typical antipsychotic medications.
Novick D; Haro JM; Bertsch J; Anand H; Jemiai N; Haddad PM
Int Clin Psychopharmacol; 2012 Sep; 27(5):275-82. PubMed ID: 22699789
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: a nationwide study in Hungary.
Bitter I; Katona L; Zámbori J; Takács P; Fehér L; Diels J; Bacskai M; Lang Z; Gyáni G; Czobor P
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1383-90. PubMed ID: 23477752
[TBL] [Abstract][Full Text] [Related]
19. Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting.
Chiliza B; Ojagbemi A; Esan O; Asmal L; Oosthuizen P; Kidd M; Gureje O; Emsley R
Early Interv Psychiatry; 2016 Feb; 10(1):54-62. PubMed ID: 24690088
[TBL] [Abstract][Full Text] [Related]
20. Changes in adherence and treatment costs following initiation of oral or depot typical antipsychotics among previously non-adherent patients with schizophrenia.
Hong J; Novick D; Brugnoli R; Bertsch J; Haro JM
Hum Psychopharmacol; 2013 Sep; 28(5):438-46. PubMed ID: 23775950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
